TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation regarding Change in Senior Management Personnel of the Company30-09-2023
30-09-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Intimation of the Closure of Trading Window29-09-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates21-09-2023
Torrent Pharma in talks with Apollo to borrow up to $1 bn for Cipla bid: Report
Torrent is hoping to secure roughly $3 billion to $4 billion in financing for the bid for its much bigger rival, the report said19-09-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates14-09-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Clarification / Information On News Item
Clarification / information on news item01-09-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Clarification sought from Torrent Pharmaceuticals Ltd
The Exchange has sought clarification from Torrent Pharmaceuticals Ltd on August 31, 2023, with reference to news appeared in ET NOW dated August 31, 2023 quoting"Torrent Pharma is in talks to acquire Cipla Ltd."The reply is awaited.31-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating24-08-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility24-08-2023
Torrent Pharmaceutical gains on USFDA relief for Dahej plant
The FDA's 'voluntary action indicated classification' means that Torrent Pharma will be now able to get approval for all pending Abbreviated New Drug Applications from the site24-08-2023